amref health africa
amref health africa Company Information
Company Number
00982544
Next Accounts
Sep 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
canopi 82 tanner street, london, SE1 3GN
Website
www.amrefuk.orgamref health africa Estimated Valuation
Pomanda estimates the enterprise value of AMREF HEALTH AFRICA at £3.6m based on a Turnover of £6.5m and 0.56x industry multiple (adjusted for size and gross margin).
amref health africa Estimated Valuation
Pomanda estimates the enterprise value of AMREF HEALTH AFRICA at £8.5m based on an EBITDA of £2m and a 4.33x industry multiple (adjusted for size and gross margin).
amref health africa Estimated Valuation
Pomanda estimates the enterprise value of AMREF HEALTH AFRICA at £12.4m based on Net Assets of £5.3m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amref Health Africa Overview
Amref Health Africa is a live company located in london, SE1 3GN with a Companies House number of 00982544. It operates in the other human health activities sector, SIC Code 86900. Founded in June 1970, it's largest shareholder is unknown. Amref Health Africa is a mature, mid sized company, Pomanda has estimated its turnover at £6.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amref Health Africa Health Check
Pomanda's financial health check has awarded Amref Health Africa a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
2 Weak
Size
annual sales of £6.5m, make it larger than the average company (£796.3k)
£6.5m - Amref Health Africa
£796.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (6.5%)
35% - Amref Health Africa
6.5% - Industry AVG
Production
with a gross margin of 36.5%, this company has a comparable cost of product (36.5%)
36.5% - Amref Health Africa
36.5% - Industry AVG
Profitability
an operating margin of 30.1% make it more profitable than the average company (5.5%)
30.1% - Amref Health Africa
5.5% - Industry AVG
Employees
with 16 employees, this is similar to the industry average (19)
16 - Amref Health Africa
19 - Industry AVG
Pay Structure
on an average salary of £52k, the company has a higher pay structure (£26.9k)
£52k - Amref Health Africa
£26.9k - Industry AVG
Efficiency
resulting in sales per employee of £404.7k, this is more efficient (£51.3k)
£404.7k - Amref Health Africa
£51.3k - Industry AVG
Debtor Days
it gets paid by customers after 9 days, this is earlier than average (22 days)
9 days - Amref Health Africa
22 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (17 days)
0 days - Amref Health Africa
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Amref Health Africa
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 298 weeks, this is more cash available to meet short term requirements (102 weeks)
298 weeks - Amref Health Africa
102 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18.2%, this is a lower level of debt than the average (27.9%)
18.2% - Amref Health Africa
27.9% - Industry AVG
AMREF HEALTH AFRICA financials
Amref Health Africa's latest turnover from December 2023 is £6.5 million and the company has net assets of £5.3 million. According to their latest financial statements, Amref Health Africa has 16 employees and maintains cash reserves of £5.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6,474,850 | 5,105,332 | 5,150,243 | 2,650,317 | 4,495,153 | 3,816,194 | 4,424,240 | 5,610,432 | 5,695,704 | 4,366,951 | 4,458,117 | 4,883,993 | 4,005,534 | 5,134,078 | 5,109,111 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 1,634,780 | 652,971 | 1,261,466 | -854,564 | -8,782 | -1,307,163 | 774,043 | 1,356,146 | 459,744 | -4,205 | -808,898 | 923,438 | -505,855 | -3,081 | -11,552 |
| Tax | |||||||||||||||
| Profit After Tax | 1,634,780 | 652,971 | 1,261,466 | -854,564 | -8,782 | -1,307,163 | 774,043 | 1,356,146 | 459,744 | -4,205 | -808,898 | 923,438 | -505,855 | -3,081 | -11,552 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 1,634,780 | 652,971 | 1,261,466 | -854,564 | -8,782 | -1,307,163 | 774,043 | 1,356,146 | 459,744 | -4,205 | -808,898 | 923,438 | -505,855 | -3,081 | -11,552 |
| Employee Costs | 831,923 | 762,511 | 748,855 | 706,781 | 752,914 | 937,843 | 585,807 | 547,186 | 443,252 | 675,507 | 634,425 | 615,754 | 626,778 | 636,145 | 627,253 |
| Number Of Employees | 16 | 18 | 17 | 13 | 16 | 17 | 14 | 14 | 11 | 17 | 16 | 16 | 17 | 17 | 17 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 14,338 | 11,525 | 8,206 | 6,005 | 9,083 | 17,585 | 14,027 | 10,268 | 4,226 | 28,955 | 46,428 | 29,232 | 16,324 | 7,430 | 20,202 |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 14,338 | 11,525 | 8,206 | 6,005 | 9,083 | 17,585 | 14,027 | 10,268 | 4,226 | 28,955 | 46,428 | 29,232 | 16,324 | 7,430 | 20,202 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 164,022 | 315,408 | 245 | 1,979 | 2,000 | 66,756 | 9,073 | 112,633 | |||||||
| Group Debtors | 31,393 | 178,531 | 201,440 | 27,544 | 62,423 | 658 | 1,127 | 2,133 | 51,285 | ||||||
| Misc Debtors | 198,996 | 136,016 | 153,809 | 100,625 | 47,975 | 397,155 | 1,605,248 | 63,673 | 23,814 | 189,653 | 65,057 | 66,465 | 94,608 | 106,661 | 1,226 |
| Cash | 5,528,778 | 4,080,072 | 3,668,120 | 2,232,268 | 3,024,012 | 2,902,310 | 2,577,213 | 3,628,722 | 2,120,722 | 2,025,255 | 1,684,312 | 1,900,035 | 958,430 | 1,464,827 | 1,451,659 |
| misc current assets | 500,000 | ||||||||||||||
| total current assets | 6,423,189 | 4,710,027 | 4,023,369 | 2,360,437 | 3,134,655 | 3,302,102 | 4,185,588 | 3,761,284 | 2,204,894 | 2,214,908 | 1,749,369 | 1,966,500 | 1,053,038 | 1,571,488 | 1,565,518 |
| total assets | 6,437,527 | 4,721,552 | 4,031,575 | 2,366,442 | 3,143,738 | 3,319,687 | 4,199,615 | 3,771,552 | 2,209,120 | 2,243,863 | 1,795,797 | 1,995,732 | 1,069,362 | 1,578,918 | 1,585,720 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 3,022 | 799 | 656 | 2,046 | 8,052 | 20,157 | 19,453 | 15,871 | 25,384 | 32,906 | 288,104 | 5,809 | 1 | ||
| Group/Directors Accounts | 183,774 | 253,078 | 146,002 | 18,620 | 10,792 | 269,197 | 61,834 | 61,604 | 177,334 | 1,060,958 | 8,638 | 10,856 | |||
| other short term finances | |||||||||||||||
| hp & lease commitments | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 38,400 | |||||||
| other current liabilities | 776,501 | 623,425 | 688,838 | 611,363 | 533,438 | 432,395 | 207,227 | 552,219 | 382,457 | 24,198 | 377,687 | 51,021 | 53,897 | 48,963 | 50,466 |
| total current liabilities | 963,297 | 882,102 | 840,296 | 636,829 | 557,082 | 726,549 | 293,314 | 634,494 | 623,575 | 1,118,062 | 665,791 | 56,830 | 53,898 | 57,601 | 61,322 |
| loans | 205,000 | 205,000 | 205,000 | ||||||||||||
| hp & lease commitments | 4,800 | 9,600 | 14,400 | 19,200 | 25,200 | 30,000 | |||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 205,000 | 205,000 | 209,800 | 9,600 | 14,400 | 19,200 | 25,200 | 30,000 | |||||||
| total liabilities | 1,168,297 | 1,087,102 | 1,050,096 | 646,429 | 571,482 | 745,749 | 318,514 | 664,494 | 623,575 | 1,118,062 | 665,791 | 56,830 | 53,898 | 57,601 | 61,322 |
| net assets | 5,269,230 | 3,634,450 | 2,981,479 | 1,720,013 | 2,572,256 | 2,573,938 | 3,881,101 | 3,107,058 | 1,585,545 | 1,125,801 | 1,130,006 | 1,938,902 | 1,015,464 | 1,521,317 | 1,524,398 |
| total shareholders funds | 5,269,230 | 3,634,450 | 2,981,479 | 1,720,013 | 2,572,256 | 2,573,938 | 3,881,101 | 3,107,058 | 1,585,545 | 1,125,801 | 1,130,006 | 1,938,902 | 1,015,464 | 1,521,317 | 1,524,398 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 5,924 | 4,477 | 3,001 | 7,199 | 8,502 | 11,426 | 3,212 | 5,946 | 24,729 | 20,901 | 20,901 | 10,612 | 11,240 | 12,772 | 13,804 |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | -235,544 | 274,706 | 227,080 | 17,526 | -289,149 | -1,208,583 | 1,475,813 | 48,390 | -105,481 | 124,596 | -1,408 | -28,143 | -12,053 | -7,198 | 113,859 |
| Creditors | 2,223 | 143 | -1,390 | -6,006 | -12,105 | 704 | 3,582 | -9,513 | -7,522 | -255,198 | 282,295 | 5,808 | 1 | ||
| Accruals and Deferred Income | 153,076 | -65,413 | 77,475 | 77,925 | 101,043 | 225,168 | -344,992 | 169,762 | 358,259 | -353,489 | 326,666 | -2,876 | 4,934 | -1,503 | 50,466 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -14,984 | -6,971 | -11,988 | ||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | -14,984 | -6,971 | -11,988 | ||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -69,304 | 107,076 | 127,382 | 7,828 | -258,405 | 207,363 | 230 | -115,730 | -883,624 | 1,060,958 | -8,638 | -2,218 | 10,856 | ||
| Other Short Term Loans | |||||||||||||||
| Long term loans | 205,000 | ||||||||||||||
| Hire Purchase and Lease Commitments | -4,800 | -4,800 | -4,800 | -4,800 | -4,800 | -6,000 | -4,800 | -3,600 | 38,400 | ||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | -74,104 | 102,276 | 327,582 | 5,349 | -256,105 | 201,363 | -4,570 | 46,037 | -845,224 | 1,060,958 | 2 | -8,636 | -2,218 | 1,546,806 | |
| cash and cash equivalents | |||||||||||||||
| cash | 1,448,706 | 411,952 | 1,435,852 | -791,744 | 121,702 | 325,097 | -1,051,509 | 1,508,000 | 95,467 | 340,943 | -215,723 | 941,605 | -506,397 | 13,168 | 1,451,659 |
| overdraft | |||||||||||||||
| change in cash | 1,448,706 | 411,952 | 1,435,852 | -791,744 | 121,702 | 325,097 | -1,051,509 | 1,508,000 | 95,467 | 340,943 | -215,723 | 941,605 | -506,397 | 13,168 | 1,451,659 |
amref health africa Credit Report and Business Information
Amref Health Africa Competitor Analysis
Perform a competitor analysis for amref health africa by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SE1 area or any other competitors across 12 key performance metrics.
amref health africa Ownership
AMREF HEALTH AFRICA group structure
Amref Health Africa has no subsidiary companies.
Ultimate parent company
AMREF HEALTH AFRICA
00982544
amref health africa directors
Amref Health Africa currently has 9 directors. The longest serving directors include Ms Jennifer Chimanga (Oct 2018) and Mr Paul Davey (Nov 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Jennifer Chimanga | England | 43 years | Oct 2018 | - | Director |
| Mr Paul Davey | England | 66 years | Nov 2019 | - | Director |
| Mrs Beverley Jewell | 64 years | Aug 2020 | - | Director | |
| Dr Tinashe Chandauka | United Kingdom | 35 years | Aug 2020 | - | Director |
| Ms Bridie Layden | England | 38 years | Aug 2020 | - | Director |
| Dr Sally Nicholas | England | 45 years | Nov 2022 | - | Director |
| Ms Navita Yadav | England | 48 years | Mar 2024 | - | Director |
| Ms Jill Anderson | England | 61 years | May 2024 | - | Director |
| Mr Andrew Tuttle | England | 39 years | May 2024 | - | Director |
P&L
December 2023turnover
6.5m
+27%
operating profit
2m
0%
gross margin
36.6%
+0.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
5.3m
+0.45%
total assets
6.4m
+0.36%
cash
5.5m
+0.36%
net assets
Total assets minus all liabilities
amref health africa company details
company number
00982544
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
June 1970
age
55
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
african medical and research foundation (united kingdom) (February 2014)
african medical & research foundation limited (April 2001)
accountant
-
auditor
BUZZACOTT LLP
address
canopi 82 tanner street, london, SE1 3GN
Bank
C HOARE CO
Legal Advisor
-
amref health africa Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to amref health africa.
amref health africa Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AMREF HEALTH AFRICA. This can take several minutes, an email will notify you when this has completed.
amref health africa Companies House Filings - See Documents
| date | description | view/download |
|---|
